Daily Financial Update
Good morning. It’s Sunday, December 14, 2025, and here’s why today matters.
Market Pulse: Tech stocks dragged major averages into the red as a sell-off steamrolled early gains.
Key Movers: Broadcom’s Q4 beat couldn’t stop a premarket slide (Crypto Briefing), while Lululemon’s $1B buyback and CEO exit spiked shares (Rolling Out; International Business Times).
Macro & Politics: FDA slapped approvals on CARDAMYST™, Nuzolvence and raxibacumab, fueling a biotech rally, and Warner Bros.’ court brawl adds governance suspense.
What’s Next: Look for Monday’s tech earnings and any Capitol chatter on FDA funding or antitrust probes.
📈 Breaking Financial News
MONTREAL and CHARLOTTE, N.C., Dec. 12, 2025 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that the U.S. Food and Drug Administration (FDA) approved its first commercial product, CARDAMYST™ (etripamil) nasal spray, a presc…
GlobeNewswire
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Thefly.com
Investor concerns over guidance updates may overshadow strong earnings, highlighting the market's sensitivity to future growth signals. The post Broadcom shares drop premarket despite Q4 earnings beat appeared first on Crypto Briefing.
Crypto Briefing
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Thefly.com
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Friday. Shares of Broadcom Inc (NASDAQ:AVGO) fell sharply in pre-market trading even after the semiconductor giant delivered fourth-quarter earnings beat and reporte…
Biztoc.com
Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse With new executi
Institutions are loading up while it still trades at a discount. Get the full intelligence for just $3.
🔍 Market Analysis & Insights
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Thefly.com
Download Sample Get Special Discount Wearable Health Devices Market Size, Strategic Outlook & Forecast 2026-2033Market size (2024): USD 40.5 billionForecast (2033): 125.
Linkedin.com
Shake Shack Inc. (NYSE:SHAK) is one of the stocks on Jim Cramer’s radar recently. A caller asked about the stock, and here’s what Mad Money’s host had to say…
Yahoo Entertainment
The dramatic escalation in the fight for Warner Bros is one of the biggest in recent corporate memory, drawing an unlikely cast of celebrities and business figures including Jared Kushner.
ABC News (AU)
Wall Street is diversifying out of tech stocks, with Broadcom the latest AI name to disappoint after earnings.
Yahoo Entertainment
Elon Musk Reveals **ULTRA** Powerful New AI Supercomputer in Memphis It's litera
James Altucher, the legendary tech investor and venture capitalist, predicts it will make Elon Musk the new King of AI – and change the lives of tech investors all over the nation. Get the shocking new details right here.
💰 Investment Opportunities
Lululemon Athletica saw its stock price surge approximately 10% in premarket trading Friday morning, climbing to $207.01 from its previous close of $187.62. The dramatic jump came after the athletic apparel retailer delivered a trio of major announcements tha…
Rolling Out
The third quarter earnings season has been mostly positive, with most of the reports in the rearview mirror.
Yahoo Entertainment
Lululemon announces CEO Calvin McDonald's exit as the company restructures amid slowing U.S. sales and rising athleisure competition.
International Business Times
Lululemon Athletica shares surged during after-hours trading after the company reported better-than-expected Q3 results and announced the departure of CEO Calvin McDonald.
International Business Times
Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be…
Yahoo Entertainment
Congress to feature Trump on $100 Bill?
A shocking new plan was just introduced in Washington. The idea is to celebrate Trump's new “golden age” by placing him on the $100 bill. As you'll see, it has little to do with the new Crypto Reserve… Or Trump's ambitious plan for Artificial Intelligence… Former Presidential Advisor, Jim Rickards says, “Trump's crowning achievement will be much, much bigger.” In the months ahead, he predicts, the government will release a massive multi-trillion-dollar asset which it has held back for more than a century. And this will give ordinary investors a chance to strike it rich. Click here to see the full details.
Market Commentary
Everyone’s overlooking how the FDA’s blitz of approvals—from Milestone’s CARDAMYST™ to Acadia’s Daybue Stix—could overheat valuations in a sector that’s already stretched. Barring a realsale catalyst, fresh labels look like temporary gold rushes, not durable gains.
Connect the dots: Lululemon’s surprise CEO exit and buyback frenzy underscore boardroom agility, while Warner Bros.’ courtroom brawl reminds us that governance and litigation often move markets just as much as earnings. Both stories show headlines driving volatility more than fundamentals.
If you’re looking for a play, focus on biotech names with genuine pipelines and avoid hype-driven buybacks. Set tight risk controls—this environment punishes complacency.